⌘K
Loading ticker…
As of 2026-08-25, SCYNEXIS, Inc. (SCYX) has a 3-month relative strength percentile of 39 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 45. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 9.3%, relative volume 0.49×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
SCYX is held by 3 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $1M notional. Top 3 carry $2M.
Held by 3 ETFs · $2M across latest filings · largest weight 0.01% (BSVO).
Top 3 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $1M | — |
| VXFVanguard Extended Market ETF | 0.00% | $385K | — |
| BSVO | 0.01% | $113K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SCYX Jan avg: 2.72% median: 2.40% win: 50% σ: 14.46% n: 4 2022-04-12 → 2026-07-31 | SCYX Feb avg: -9.60% median: -11.27% win: 25% σ: 12.71% n: 4 2022-04-12 → 2026-07-31 | SCYX Mar avg: 26.69% median: 7.34% win: 50% σ: 51.83% n: 4 2022-04-12 → 2026-07-31 | SCYX Apr avg: 0.83% median: 3.76% win: 80% σ: 13.26% n: 5 2022-04-12 → 2026-07-31 | SCYX May avg: -6.86% median: -20.64% win: 20% σ: 28.22% n: 5 2022-04-12 → 2026-07-31 | SCYX Jun avg: -12.35% median: -17.18% win: 20% σ: 18.00% n: 5 2022-04-12 → 2026-07-31 | SCYX Jul avg: 10.38% median: 6.50% win: 100% σ: 10.63% n: 5 2022-04-12 → 2026-07-31 | SCYX Aug avg: 4.47% median: 14.42% win: 75% σ: 24.45% n: 4 2022-04-12 → 2026-07-31 (current) | SCYX Sep avg: -11.42% median: -6.26% win: 25% σ: 16.37% n: 4 2022-04-12 → 2026-07-31 | SCYX Oct avg: -10.97% median: -11.51% win: 0% σ: 5.94% n: 4 2022-04-12 → 2026-07-31 | SCYX Nov avg: -0.91% median: 1.45% win: 75% σ: 6.98% n: 4 2022-04-12 → 2026-07-31 | SCYX Dec avg: -5.30% median: -10.02% win: 25% σ: 27.78% n: 4 2022-04-12 → 2026-07-31 |